![](../../../getData/retreiveOnePIC.php?unit=656&img=624_1_1_22 5 3.jpg)
MAY
Symposium of Dr. / Ashraf Omar El-Feke .. with the various faculties in the branch
From the symposium of Dr. Ashraf Omar El-Feki (Consultant of Clinical Research and Immunology at IMS-Washington),
Under the title :
"A life of a drug from Discovery to Market"
Today is Sunday 5/22/2022
About Dr. Ashraf El-Feki
1- Supervising, directing and evaluating clinical clinical trials for immunomodulating treatments (serology and gene therapy) in one of the most important global expertise houses responsible for designing and implementing clinical trials in the United States of America at its headquarters in Washington (2014 until now)
2- He worked as a medical researcher at the American Medical Research and Institutes Authority (NIH) and then in charge of the Biological Therapy Evaluation Center (serum, vaccine and gene therapy) at the US Drug Safety Authority (FDA) in Washington (2006-2014).
3- Participated in supervising the clinical and immunological trials of the Ebola vaccine until it was approved by the FDA
4- After graduating from Alexandria medicine, he completed his higher studies, ending with obtaining a diploma from Harvard University and a master’s and doctorate in genetics and immunology from the University of California
5- He completed his clinical training qualified for the American Board of Laboratory Medicine.
6- In 2019, he contributed to the drafting of a scientific paper in which international experts participated in structuring the specialization of clinical trials and drug research in Africa and the Middle East.
7- In 2020, Harvard University invited him to give a lecture on Covid-19 vaccine research
8- He received the Excellence Award from the University of California, the President of the American Drug Safety Authority Award, and the Shield of Appreciation for his efforts in Ebola vaccine research.